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Abstract: Several classes of copper complexes are known to induce oxidative DNA damage that
mediates cell death. These compounds are potentially useful anticancer agents and detailed investigation can reveal the mode of DNA interaction, binding strength, and type of oxidative lesion formed.
We recently reported the development of a DNA electrochemical biosensor employed to quantify the
DNA cleavage activity of the well-studied [Cu(phen)2 ]2+ chemical nuclease. However, to validate the
broader compatibility of this sensor for use with more diverse—and biologically compatible—copper
complexes, and to probe its use from a drug discovery perspective, analysis involving new compound
libraries is required. Here, we report on the DNA binding and quantitative cleavage activity of the
[Cu(TPMA)(N,N)]2+ class (where TPMA = tris-2-pyridylmethylamine) using a DNA electrochemical
biosensor. TPMA is a tripodal copper caging ligand, while N,N represents a bidentate planar phenanthrene ligand capable of enhancing DNA interactions through intercalation. All complexes exhibited
electroactivity and interact with DNA through partial (or semi-) intercalation but predominantly
through electrostatic attraction. Although TPMA provides excellent solution stability, the bulky
ligand enforces a non-planar geometry on the complex, which sterically impedes full interaction.
[Cu(TPMA)(phen)]2+ and [Cu(TPMA)(DPQ)]2+ cleaved 39% and 48% of the DNA strands from
the biosensor surface, respectively, while complexes [Cu(TPMA)(bipy)]2+ and [Cu(TPMA)(PD)]2+
exhibit comparatively moderate nuclease efficacy (ca. 26%). Comparing the nuclease activities of
[Cu(TPMA)(phen)]2+ and [Cu(phen)2 ]2+ (ca. 23%) confirms the presence of TPMA significantly
enhances chemical nuclease activity. Therefore, the use of this DNA electrochemical biosensor is
compatible with copper(II) polypyridyl complexes and reveals TPMA complexes as a promising class
of DNA damaging agent with tuneable activity due to coordinated ancillary phenanthrene ligands.
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Life expectancy has risen significantly during the last few decades due to better accessibility to health care, education, clean water, and sufficient food. During an average
lifetime people therefore experience greater exposure to mutagenic substances and suffer
age-related losses to cellular function, increasing the chances of permanent DNA damage [1].
It is not surprising then that the number of people diagnosed with cancer is incrementing year-on-year [2]. This trend has emphasised the need for developing effective new
anticancer drugs with high specificity, tailored to the individual [3].
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Many bioinorganic compounds containing transition metals such as Pt, Ru, Ag, Cu,
and Mn exhibit anticancer properties [4–8] with a number undergoing clinical trial [9–11].
Among these, copper complexes have proved interesting as their biological activity is
closely linked to redox cycling through several oxidation states—Cu(I) and Cu(II) [4]. Their
biological and physicochemical properties are also highly dependent on the chelating ligands used in their construction [12,13]. The type and shape of the Cu-coordinated organic
scaffold defines the DNA-interaction of the metal complex, which can bind through intercalation, groove binding, or electrostatic interactions [12]. Upon DNA-binding, the metal
complex mediates DNA cleavage by hydrolysis of the DNA backbone or by oxidation of
DNA sugars or bases [14]. Many copper complexes, in the presence of reductant (ascorbate,
glutathione, or NADH) and an oxidant (H2 O2 or O2 ), generate reactive oxygen species
(ROS) through Fenton-like [15,16] or other radical-generating mechanisms [17]. These ROS
induce damage to DNA, such as the oxidation of bases (e.g., 8-oxoguanine) or to the sugar
unit through C–H activation, that result in single- or double-strand DNA breaks [18]. Since
the type of DNA damage induced here differs from classical platinum(II) therapy, copper
complexes might therefore circumvent existing clinical treatment limitations—especially
for recalcitrant cancers of the breast, brain, and pancreas [19,20].
The first reported copper-based complex to exhibit oxidative chemical nuclease activity was [Cu(phen)2 ]2+ [21]. In recent years, many related copper complexes have been
prepared and their chemical nuclease activity explored both biologically and chemically
not only in the context of anticancer drug discovery [5,14,22,23], but also for applications
in gene-directed cleavage [24–27] and protein engineering [28]. Chemical nuclease activity is usually examined using gel electrophoresis techniques [29–31], further advanced
through lab-on-a-chip technology [32]. These methodologies yield valuable insight into
the ligand-directed DNA nuclease mechanisms of copper complexes [33]. Attempts to
create electrochemical methods to detect DNA cleavage events induced by bioinorganic
complexes, have also been reported [34–36]. However, these techniques do not provide
quantitative data regarding nuclease efficacy and site-specific cleavage. In the current work,
the chemical nuclease activities of a new class of copper complex was examined using a
quantitative electrochemical method described recently by us [37]. Here, the DNA surface
coverage of the biosensor is measured before and after its exposure to the copper nuclease
in the presence of reductant and oxidant. Upon DNA cleavage, nucleic acid fragments are
released from the immobilised DNA on the electrode surface. This decrease in the DNA
surface coverage can be determined electrochemically and presented as the percentage in
nuclease efficacy of the complex.
The copper complex class explored herein contain a tris-2-pyridylmethylamine (TPMA)
caging ligand and one bidentate ligand selected from: 1,10-phenanthroline (phen); 2,20 bipyridine (bipy); dipyridoquinoxaline (DPQ); or 1,10-phenanthroline-5,6-dione (PD).
TPMA is a tripodal ligand that alone, and as part of a complex with copper, exhibits cytotoxicity against several cancer cell lines [38]. Planar bidentate phenanthrene ligands, on the
other hand, are known to interact with nucleic acids by intercalation or semi-intercalation
and coordinate a copper ion via N,N ligation. Importantly, the generation of radical species
at the DNA interface by this class leads to strand excision [32,39]. Although the DNA
binding and damaging properties of copper, cobalt, and ruthenium complexes of TPMA
have been reported [40–43], these interactions have not, as yet, been characterised using
DNA electrochemical biosensors.
In this work, the electrochemical and chemical nuclease properties of copper TPMA
complexes were characterised using DNA electrochemical biosensor, recently employed in
the analysis of [Cu(phen)2 ]2+ —an agent which semi-intercalates and cleaves DNA from
the minor groove [37]. Herein, the DNA binding and quantitative cleavage activity of the
[Cu(TPMA)(N,N)]2+ class is reported using a DNA electrochemical biosensor. These results
not only validate the broader compatibility of our DNA sensor for use with polypyridyl
complexes, but they also provide valuable drug discovery information related to target
identification and selection.
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Figure 1. Typical cyclic voltammograms registered in O2 -free solutions at the bare gold electrode,
scan rate 100 mV s−1 , in 0.1 M PB, pH 7.0 (black solid trace): (a) 20 µM of [Cu(TPMA)(phen)]2+ (red
dashed trace), [Cu(TPMA)(bipy)]2+ (blue double trace) and [Cu(TPMA)(DPQ)]2+ (green dotted trace),
(b) 20 µM of [Cu(TPMA)(PD)]2+ (red dashed trace).

Complications due to the electrochemistry of gold oxide monolayer formation were
prevented by removing dissolved oxygen from the solutions. To determine how the
individual peaks are correlated with one another, additional measurements in narrower
potential windows were performed for [Cu(TPMA)(phen)]2+ and [Cu(TPMA)(PD)]2+ (S-3,
Figures S2–S9, SM).
In measurements performed for [Cu(TPMA)(phen)]2+ , it was determined that the
C1 /A1 peaks are coupled. The C2 redox process occurs only when it is preceded by an A2
oxidation event and, thus, the C2 /A2 are also coupled. The C2 peak was not observed in our
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studies of [Cu(phen)2 ]2+ [37], hence, its appearance is linked to the presence of the TPMA
ligand in [Cu(TPMA)(phen)]2+ . This was verified by electrochemical characterisation of
[Cu(TPMA)]2+ under the same conditions which returned redox potential comparable
to those reported in polyelectrolyte [45] (S-3, Figure S4, SM). A plausible justification is
that after reduction from [Cu(TPMA)(phen)]2+ to [Cu(TPMA)(phen)]+ , C1 , the complex
undergoes structural reorganisation, and subsequent electron transfer, described by the
reduction event, C2 . Elucidation of the mechanism involved here requires further study
but may be indicative of dissociation of one of the TPMA chelating N atoms to generate
a five-coordinated species [17] (structurally—and possibly chemically—distinct from the
initial complex). A similar interpretation can be applied to the C1 /A1 and C2 /A2 redox
processes of [Cu(TPMA)(bipy)]2+ and [Cu(TPMA)(DPQ)]2+ . The proposed electrochemical
behaviour in aqueous solution justifies the two observed redox couples, referred to hereafter
as ‘Cu(TPMA)’ and ‘Cu(N,N0 )’ character, and DNA nuclease properties observed at the
DNA modified electrodes, for these complexes.
In measurements performed on [Cu(TPMA)(PD)]2+ , it was determined that the C1 /A1
redox coupled is ascribed to the ‘Cu(PD) character’ of the complex and C3 /A3 can be associated with the reversible oxidation of the 1,10-phen-5,6-dione (PD) ligand. Transition metal
PD complexes can undergo a two-step 2 electron reduction [46–48], while the reduction
of the free PD ligand in aqueous solution, from quinone to semiquinone and further to
hydroquinone, has also been reported [49,50] (S-3, Figure S7, SM). Moreover, the C2 peak,
also common to the other complexes at −0.4 V, is linked to the A2 oxidation processes and
describes the electroactivity of the reorganised complex (‘Cu(TPMA) character’).
In general, at both bare and DNA modified gold electrodes, one redox event (C1 /A1 ),
Cu(N,N0 ) character’, was recorded at similar potentials for all copper complexes and is
comparable to the C1 /A1 data obtained for [Cu(phen)2 ]2+ (Table 1), while the C2 /A2
couples describe the ‘Cu(TPMA) character’ redox behaviour of the complexes:

[Cu(TPMA)( N, N )]2+

[Cu(TPMA)( N, N )]+ + e−

Table 1. The values of C1 /A1 and C2 /A2 redox couple anodic and cathodic peak potentials at bare
gold electrodes.
Ep,C1/Ep,A1 [V]
ΔEp,C1/A1 [mV]
Ep,C2/Ep,A2 [V
Complex
2+

Complex
[Cu(TPMA)(Phen)]2+
[Cu(TPMA)(DPQ)]2+
[Cu(TPMA)(Bipy)]2+
[Cu(TPMA)(PD)]2+
[Cu(TPMA)]2+
✻

[Cu(Phen)2 ]2+

∆Ep,C1/A1
Ep,C1 /Ep,A1[Cu(TPMA)(Phen)]
[V]
[mV]2+
[Cu(TPMA)(DPQ)]
−0.18/+0.30
480 2+
[Cu(TPMA)(Bipy)]
−0.21/+0.23
4402+
[Cu(TPMA)(PD)]
−0.19/+0.35
540
2+
[Cu(TPMA)]
−0.07/−0.04
30 2+
✻
]
2
−0.21/+0.01 [Cu(Phen)
220

−0.20/−0.08

120

−0.18/+0.30
Ep,C2 /Ep,A2 [V]
−0.21/+0.23
−0.46/+0.30
−0.19/+0.35
−0.46/+0.23
−0.07/−0.04
−0.45/+0.35
−0.21/+0.01
−0.43/+0.27
−0.20/−0.08
−0.42/+0.22

NA

480
∆Ep,C2/A2
440 [mV]

760
540
590
30
800
220
700
120
640

−0.46/+0.30
−0.46/+0.23
−0.45/+0.35
−0.43/+0.27
−0.42/+0.22

NA

Scan rate 100 mV s−1 , in 0.1 M PB, and the separation between these potentials, ∆Ep. ✻ From reference [37].

With the exception of [Cu(TPMA)(PD)]2+ , where reversible redox behaviour is observed in the C1 /A1 couple (∆Ep, C1/A1 = 30 mV), large peak separation values indicate
that both C1 /A1 and C2 /A2 redox couples were electrochemically irreversible (∆Ep,
C1/A1 > 440 mV and ∆Ep, C2/A2 > 590 mV) at the bare gold electrode. The C2 reduction
peaks for all copper complexes were registered at similar potentials, whereas the oxidation
peaks were observed at positive potential values (>0.23 V). When compared to that of
[Cu(phen)2 ]2+ , it is apparent that the C1 /A1 couple potentials are dictated by the presence
of the TPMA ligand. The sluggish A2 oxidation processes may indicate that, in terms of
complex stability, the reduced state, Cu(I), is favoured, i.e., once reduced, re-oxidation of
the complexes is kinetically difficult. These potential values show that differences in the
structures of the complexes have a significant bearing on the respective redox properties.

NA
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2.2. Electrochemical Characterisation of [Cu(phen)2 ]2+ , [Cu(TPMA)]2+ and the TPMA Ligand at
the DNA Biosensor
To interpret the data obtained for [Cu(TPMA)(N,N0 )]2+ , electrochemical analysis of
[Cu(phen)2 ]2+ , [Cu(TPMA)]2+ and the TPMA ligand at the DNA biosensor was carried
out (Figure 2). The redox peaks for [Cu(phen)2 ]2+ were clearly visible at −0.12 V (C1 )
and −0.07 V (A1 ) vs. SCE (Figure 2a). This redox process can be associated with the
reduction and oxidation of the complex, [Cu(phen)2 ]2+ /[Cu(phen)2 ]+ , mediated by the
immobilised DNA layer via long-range electron transfer. A peak potential separation, ∆Ep,
of 50 mV, and the ratio between the oxidation and reduction peak currents, Ip,a /Ip,c > 2,
indicate that the redox reaction is quasi-reversible. The electrochemistry of this compound
is discussed in detail elsewhere. An ill-defined C1 /A1 redox couple was evident for
[Cu (TPMA)]2+ (Figure 2b). The small reduction C1 peak appears at a potential similar
to that for [Cu(phen)2 ]2+ but the oxidation A1 peak is shifted to a much more positive
potential value. The differences in the redox potentials between the complexes are directed
by the variations in complex structure and ligand type. The planar aromatic ligand of
[Cu(phen)2 ]2+ facilitates the partial intercalation of the complex within DNA bases [51] and
the complex redox reaction is then mediated via long-range electron transfer.
The bulky non-planar TPMA ligand impedes intercalation between DNA bases, precluding close contact between the complex and DNA; hence, the electrochemical response
of this complex is less well-defined than that observed for [Cu(phen)2 ]2+ . An additional
reduction peak C2 , at −0.42 V vs. SCE, (not observed in [Cu(phen)2 ]2+ ) can be linked to the
presence of TPMA ligand in the complex, confirmed by the single small reduction peak
(C2 ) at −0.40 V vs. SCE for the TPMA ligand alone (Figure 2c). The presence of this peak
indicates that the TPMA ligand can be reduced via DNA-mediated electron transfer.
The TPMA ligand consists of three pyridine rings that can, in theory, be reduced when
free in solution [52]. The pyridine ring (pKa 5.2 [53]) after protonation in PB, pH 7.0, can
undergo a one electron reduction to the pyridinyl radical (S-4, Figure S10, SM). Finally, the
C2 peak current was ca. 15 times larger for [Cu(TPMA)]2+ than for the uncharged TPMA
ligand alone, for the same concentration of compounds—evidence of a synergistic effect
between the redox active copper and TPMA ligand, coupled to electrostatically-facilitated
complex interaction with the immobilised DNA strands.
2.3. Electrochemical Characterisation of [Cu(TPMA)(N,N0 )]2+ Complexes at the DNA Biosensor
Two prominent redox couples (C1/A1 and C2/A2) were observed for [Cu(TPMA)(phen)]2+
and [Cu(TPMA)(DPQ)]2+ at the DNA biosensor (Figure 3). Analysis of the peak potentials
(S-5, Table S1, SM) indicate that the C1 /A1 redox processes are quasi- reversible, while
the C2 /A2 processes tend toward irreversibility [54]. The C1 /A1 redox waves, observed
for [Cu(TPMA)(phen)]2+ and [Cu(phen)2 ]2+ , occur at similar potentials indicating that
both are related to the same redox event, i.e., representing the ‘[Cu(phen)2 ]2+ electronic
character’ of the [Cu(TPMA)(phen)]2+ complex. The C2 /A2 wave was observed for all
copper complexes except for [Cu(phen)2 ]2+ , which suggests that the redox wave observed
at these potentials is directed by the presence of the TPMA ligand. In support of this
assignment, the C2 reduction peak appears at very similar potentials for [Cu(TPMA)]2+ and
[Cu(TPMA)(N,N0 )]2+ at the DNA biosensors. Thus, the C2 /A2 redox wave is associated
with the ‘[Cu(TPMA)]2+ electronic character’ of the complex. Copper complexes containing
TPMA have shown solvent-dependent coordination spheres—five-coordinate in H2 O (no
salts present) and mixed five and six-coordinate in organic solvent [17]. Data generated
at the DNA modified electrodes seem to indicate that the complexes are six-coordinate in
phosphate buffer and the dissociation of one Cu–N dative bond in aqueous solution generates a single unoccupied catalytic site within the complexes. This structural reorganisation
would seem to justify the distinct mixed redox behaviour observed in these complexes at
DNA modified electrodes.
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(no salts present) and mixed five and six-coordinate in organic solvent [17]. Data generated at the DNA modified electrodes seem to indicate that the complexes are six-coordinate in phosphate buffer and the dissociation of one Cu–N dative bond in aqueous solution generates a single unoccupied catalytic site within the complexes. This structural re7 of 17
organisation would seem to justify the distinct mixed redox behaviour observed in these
complexes at DNA modified electrodes.
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biosensor for [Cu(TPMA)(bipy)]2+ reveals the presence of C1 /A1 and C2 /A2 redox couples
and an additional oxidation peak A3 (Figure 4). The C1 peak is ill-defined compared to
that observed for [Cu(TPMA)(phen)]2+ and [Cu(TPMA)(DPQ)]2+ indicating a less facile
reduction reaction occurs in [Cu(TPMA)(bipy)]2+ . Moreover, the C1 /A1 redox process
appeared to be irreversible in contrast to the results obtained for [Cu(TPMA)(phen)]2+ and
[Cu(TPMA)(DPQ)]2+ (Table S2).
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The C2 /A2 redox couple, the ‘[Cu(TPMA)]2+ character’ of the complex, was evident
−0.42/−0.33 V vs. SCE. After 60 min, at the same DNA sensor, the peaks expanded and
shifted over time (Figure 5b). Moreover, an additional peak (A3 ) at +0.14 V became evident.
The changes in the electrochemical behaviour of the complex could be due to disruption of
the DNA layer and further insertion of the complex within the DNA strands.
The [Cu(TPMA)(PD)]2+ , in contrast to the other studied complexes, was not easily
removed by washing from the DNA layer. Some [Cu(TPMA)(PD)]2+ redox activity was
recorded at the DNA biosensor in pure PB up to two days after exposure of the biosensor
to the [Cu(TPMA)(PD)]2+ solution (S-6, Figure S11, SM). Despite washing, the presence of
the complex in the layer for an extended period of time suggests that the complex interacts
with DNA in a covalent manner. According to the literature, some quinones can covalently
bind to DNA bases, creating DNA adducts [59,60].
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2.4. DNA Nuclease Efficacy of Copper Complexes
Double-strand DNA breaks (DSBs) mediated by the copper complexes in the presence
of an exogenous oxidant and reductant were monitored electrochemically using the DNA
biosensors. The biosensors do not distinguish independent DSBs from proximate single
strand breaks (SSBs) leading to double strand cleavage and in this assay, detection of the
latter is likely given our earlier nicking observations by [Cu(TPMA)(N,N)]2+ complexes
with supercoiled pUC19 DNA [17]. The DNA surface coverages of the DNA biosensors
were measured, prior to exposure to the copper complex nuclease assays, in 10 mM TrisHCl, pH 7.4, using RuHex as a redox probe [37,61]. The DNA biosensors were then exposed
to a nuclease assay containing 10, 20, and 50 µM of the complex, 1 mM ascorbic acid (AA)
as the reductant and 1 mM H2 O2 as the oxidant in 0.1 M PB, pH 7.0, at 37 ◦ C for two
hours. The DNA surface coverage was measured again after cooling and washing the
DNA biosensor. The DNA layer washing is essential to ensure that the components of
the nuclease assay are removed from the DNA layer and do not affect the subsequent
interactions between DNA and RuHex. The changes in the DNA surface coverage values
are then the consequence of DNA cleavage from the electrode surface. The cleavage efficacy
(C.E.) can be then calculated as shown in Equation (1):
!
Γ DN A a f ter nuclease assay
C.E. = 100 % −
(1)
× 100%
Γ DN A be f ore nuclease assay
Since the Oligo DNA was 30 base pairs long, the number of cleaved base pairs was
calculated as follows, Equation (2):
!
Γ DN A a f ter nuclease assay
BP Cleaved = 30 bp −
× 30 bp
(2)
Γ DN A be f ore nuclease assay
The nuclease activities of all copper complexes at concentrations of 10, 20, and 50 µM
are presented in Figure 6. Individual data sets for the nuclease and control experiments,
with %RSD values, are available in the supporting information (S-9, Tables S3–S6, SM). All
measurements were performed in triplicate using DNA biosensors freshly prepared for
each measurement. The control measurements for this method, namely, the oxidant alone,
the reductant alone and a mixture of the reductant and oxidant have no effect on the DNA
surface coverage and are published elsewhere [37]. It was determined that the presence of
a small amount of ACN (up to 1% v/v checked, S-2, Figure S1, SM) in the solution did not
affect the DNA surface coverage values. Moreover, the complexes alone, in the absence of
an exogenous reductant and oxidant, did not cause DNA cleavage.
[Cu(TPMA)]2+ was found to cause insignificant DNA cleavage, 5.36% (%RSD 7.50%)—
estimated as one base pair, in the presence of an exogenous reductant and oxidant. The
non-planar geometry of TPMA dictates the proximity of the copper centre of the complex
to the DNA strands. A relatively large distance between the copper centre and the DNA
strands limits the ability to cleave DNA as the potency and frequency of radical species
generated by the complex are greatly diminished. This result is in good agreement with
results already published for this complex. Humphreys et al. first examined the nuclease
activity of [Cu(TPMA)]2+ using plasmid DNA and radiolabelled sequences [40,41]. In that
work, the complex did not cause double-strand breaks in any of the tested DNA types;
however, [Cu(TPMA)]2+ did cause single-strand breaks in the plasmid. The same effect was
observed by us on plasmid DNA [17] and in the current study it is likely proximate single
strand breaks by [Cu(TPMA)]2+ gives rise to the observed base pair cleaved. In contrast
to this finding, the [Cu(TPMA)(N,N)]2+ complexes exhibited high cleavage activity under
the same conditions. Planar aromatic ligands in complexes enhance the binding activity
0
between DNA and complex [17] and the redox properties of the complex (different E0
values for different complexes), having a marked effect on the observed nuclease efficacies.
Previous studies have shown that superoxide radical and hydrogen peroxide generation
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main roles in the DNA damage induced by the [Cu(TPMA)(N,N)]2+ family. Moreover,
11 of 17
some evidence of DNA damage associated with deamination of adenine (via the creation
of deoxyinosine) was evident [17].
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hydrogen peroxide generation play main roles in the DNA damage induced by the
DNA strands, facilitating more efficient DNA mediated charge transfer. Enhanced redox
[Cu(TPMA)(N,N)]2+ family. Moreover, some evidence of DNA damage associated with
cycling leading to efficient in situ generation of ROS results in a complex with potent DNA
deamination of adenine (via the creation of deoxyinosine) was evident [17].
cleavage properties.
2+ exhibited high nuclease activity, even in small conIn this work, [Cu(TPMA)(phen)]
The [Cu(TPMA)(bipy)]2+ complex did not exhibit significant DNA cleavage
at concentrations (S-9, Table S3, SM). Comparatively, 10 μM [Cu(TPMA)(phen)]2+ cleaved as
centrations of 10 µM and 20 µM (S-9, Table S5, SM). Moderate cleavage was observed only
much
from
the electrodes
50 μM
of [Cu(phen)
2]2+ (23%) under the same experiwhen DNA
a 50 µM
concentration
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These
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that an excess of the complex
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double-strand
breaks (again
resulting
from proximate SSBs).
Accordto
the
of thecopper
TPMAcomplexes
ligand enhancing
complexdo
solution
stability.
The ligand
ing
topresence
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someserving
degree,tolikely
duethe
enhanced
solution
stability
leading to enthe
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nuclease
efficacy
in
comparison
to
[Cu(phen)
2]2+. This effect was evident for the
creation of a favourable redox environment, promoting radical formation.
2+ did 2+
family[Cu(TPMA)(PD)]
of [Cu(TPMA)(N,N′)]
analogues
presented
here.in the absence of exogenous oxidant
not
exhibit nuclease
activity
2+ in the presence of the reductant and oxidant exhibited the high[Cu(TPMA)(DPQ)]
and reductant (S-9, Table S6, SM). However, the electrochemical profile of [Cu(TPMA)(PD)]2+
est
nucleaseatefficacy
of biosensors
all complexes
(S-9,
Table of
S4,exogenous
SM). A concentration
50 μM
registered
the DNA
(in the
absence
oxidant and of
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[Cu(TPMA)(DPQ)]2+ cleaves almost half of the DNA strands present on the electrode surface. The nuclease activity of a copper complex containing a DPQ ligand,
[Cu(DPQ)2(H2O)]2+, was also reported by Santra et al. [62], with the cleavage of plasmid
DNA observed on an agarose gel. The DNA degradation was more extensive for
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reveals that the complex disrupts the DNA duplex significantly over time (Figure 5).
The observed changes in the oxidation and reduction peaks then are not associated with
DNA ablation from the electrode surface but are likely representative of a covalent DNA
binding process. Conversely, in the presence of the exogenous reductant and oxidant,
[Cu(TPMA)(PD)]2+ exhibits moderate and concentration dependent DNA cleavage.
3. Materials and Methods
3.1. Materials
[Cu(phen)2 ](NO3 )2 and the copper complexes of the general formula: [Cu(TPMA)(N,N0 )]2+
were synthesised as reported [17,44]. The [Cu(TPMA)(N,N0 )]2+ complexes were dissolved
in acetonitrile (ACN) prior to further dilution in phosphate buffer (PB). The final concentration of ACN in the PB solutions of the complexes did not exceed 0.2% (v/v). Ruthenium(III)
hexaamine trichloride 98% and 4-mercaptotoluene 98% were purchased from Fisher. All
other chemicals were of analytical grade and were purchased from Sigma–Aldrich. DNA
oligomers containing 30 nucleotides were also purchased from Sigma–Aldrich and had the
following sequences:
Thiol-modified strand: SH-(CH2 )6 - 5’-AGTACAGTCATCGCTTAATTATCGTACGTA-3’
Complementary strand: 3’-TCATGTCAGTAGCGAATTAATAGCATGCAT-5’.
DNA strands were hybridised prior to use according to the procedure provided by
Sigma–Aldrich, Arklow, Ireland. Argon gas of technical grade was purchased from Air
Products. Nuclease-free water was used for the preparation of the oligo DNA solutions,
while Milli-Q® water was used to prepare all other solutions.
3.2. Equipment
The electrochemical measurements were performed with a CH Instruments, Inc. (IJ
Cambria Scientific Ltd., Llanelli, UK) potentiostat, model 620A. DNA-modified gold electrodes (2 mm diameter, from CH Instruments, Inc.), a saturated calomel electrode (SCE,
from BAS Inc., West Lafayette, IN, USA) and a platinum wire (from Surepure Chemetals,
Florham Park, NJ, USA) were used as the working, reference, and counter electrodes,
respectively. The preparation of the DNA-modified gold electrodes (DNA biosensors) is
described in S-1, Supplementary Materials (SM). All glassware in contact with DNA was
silanised to offset adsorption of DNA from solutions [64]. Prior to DNA immobilisation,
bare gold electrodes were cleaned by manual polishing with a 0.05 µm Al2 O3 slurry on
Buehler microcloth for 5 min, followed by electrochemical cycling in 0.5 M deaerated
H2 SO4 , over the potential range −0.2 V to +1.5 V vs. SCE at a scan rate of 100 mV s−1 ,
until steady-state current was attained. The thiol-modified gold electrodes were cleaned
by electrochemical desorption of thiols through cycling in 0.5 M KOH, over the potential
range +0.1 V to −1.4 V vs. SCE at a scan rate of 50 mV s−1 , followed by manual polishing
on microcloth with 0.05 µm Al2 O3 for 5 min. The supporting electrolyte was deoxygenated
with argon before measurements and a blanket of argon was maintained above the solutions during measurements. The electrochemical measurements were performed at room
temperature, while the chemical nuclease assays were carried out at 37 ◦ C.
3.3. Interactions between Immobilised DNA and Bioinorganic Compounds
The interactions between the complexes and DNA were deciphered through analysis
of the electrochemical profile of the compound in the absence and presence of DNA [55]. If
the E0’ value, estimated as the mean peak potential for the redox couple of the complex,
shifts to more positive potentials in the presence of DNA, the complex was interpreted to
interact with DNA predominantly through intercalation. If the E0’ value shifts to more
negative potentials, the interactions between DNA and the compound was interpreted as
predominantly electrostatic.
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3.4. Determination of DNA Surface Coverage
The DNA surface coverage was measured electrochemically using ruthenium(III)
hexaamine (RuHex) as a redox probe [37,61,65]. In low ionic strength electrolyte (10 mM
Tris-HCl), the positively charged RuHex interacts with DNA electrostatically, as an external
binder, replacing the existing phosphate backbone counterions (Na+ or K+ ). The amount of
RuHex molecules adsorbed in the DNA strands can be determined electrochemically using
chronocoulometry. Upon DNA layer saturation, the number of adsorbed RuHex molecules
is proportional to the number of phosphate groups in the DNA strands. Hence, knowing the
number of phosphate groups present in the custom DNA strands (one nucleotide contains
one phosphate group), the amount of adsorbed RuHex can be related to the number of
DNA molecules immobilised at the electrode surface. After each aliquot addition of RuHex,
and prior to data acquisition, the solution was allowed to equilibrate with the DNA sensor
for two minutes.
3.5. Electrochemical Measurements and Nuclease Assay Conditions
Each measurement was performed independently on freshly prepared electrodes in
0.1 M phosphate buffer (PB), pH 7.0, containing 20 µM of the complex. Cyclic voltammetry
was carried out over the potential range +0.5 V to −0.6 V vs. SCE, at a scan rate of 0.1 V
s−1 . The [Cu(TPMA)(N,N0 )]2+ solutions were allowed to equilibrate with the DNA sensors
for 20 min prior to characterisation using cyclic voltammetry. To promote solubility in PB,
the complexes were first dissolved in ACN, and aliquots were then added to PB (amount
of ACN in PB was 0.2% v/v). The addition of ACN to PB does not affect the integrity
of the DNA layer (S-2, Figure S1, SM). Chronocoulometry was then performed over the
potential range +0.1 V to −0.6 V vs. SCE with a pulse width of 0.5 s. The DNA biosensor
was exposed to the DNA nuclease assay, comprising of 10 µM, 20 µM, or 50 µM of the
chosen complex, 1 mM of sodium-L-ascorbate (AA) and 1 mM of H2 O2 for two hours at
37 ◦ C.
4. Conclusions
The copper complexes investigated in this work were all found to be electroactive
and interact with DNA predominantly through electrostatic attraction. The intercalation of
planar aromatic bidentate ligands, such as 1,10-phenanthroline and DPQ, was hindered
due to the bulky TPMA scaffold. The electrochemical response of [Cu(TPMA)(bipy)]2+
was dominated by the ‘[Cu(TPMA)]2+ character’ of the complex. It was also found that
[Cu(TPMA)(PD)]2+ caused strong disruption of the DNA layer over time and remains
within the DNA layer for an extended period of time even after washing. Dissociation
was not observed in any of studied complexes under our experimental conditions, which
corroborates earlier EPR results. Detailed investigations into the nuclease activity toward
immobilised DNA strands provided an interesting array of results. Firstly, in the presence
of an exogenous reductant and oxidant, [Cu(TPMA)(phen)]2+ and [Cu(TPMA)(DPQ)]2+
displayed relatively high nuclease activity by cleaving 39% and 48% of the DNA strands
at 50 µM drug-loading, respectively. Under the same conditions, [Cu(TPMA)(bipy)]2+
and [Cu(TPMA)(PD)]2+ exhibit moderate nuclease efficacy with ca. 26% cleavage activity detected for both agents. Although the [Cu(TPMA)]2+ complex alone displays poor
chemical nuclease activity, coordination of phen or DPQ promotes excellent cleavage ability. The type of ancillary ligand present also significantly affects both the DNA binding
activity and oxidative DNA damage induced. Although electrostatic forces dominate DNA[Cu(TPMA)(N,N)]2+ interactions, the intercalative properties of phen and DPQ facilitate
greater accessibility to DNA bases. Consequently, greater electronic communication to
the DNA base pairs grant [Cu(TPMA)(phen)]2+ and [Cu(TPMA)(DPQ)]2+ enhanced DNA
cleavage abilities, through more efficient DNA mediated redox cycling, and concomitant
in situ generation of reactive oxygen species. This assertion may seem to contradict data
gleaned for [Cu(TPMA)(PD)]2+ , but based on electrochemical behaviour observed at the
DNA biosensors in the absence of exogenous reagents, we postulate that PD-initiated
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DNA coupling reactions occur that compete with the DNA oxidative damage pathway,
limiting the nuclease efficacy observed for this complex. Overall, DNA electrochemical
biosensors appear highly suitable for analysing copper polypyridyl complexes and can
provide valuable structure-activity-relationship (SAR) data from both DNA damage and
drug discovery perspectives. It appears TPMA provides strong solution stability that
stabilises the Cu(I) oxidation state of this complex series thereby facilitating the generation of reactive oxygen species. Despite the predominant electrostatic interaction of
[Cu(TPMA)(phen)]2+ with DNA, its nuclease activity was higher than the known DNA
semi-intercalator, [Cu(phen)2 ]2+ . The results obtained here clearly show how the ligand
scaffold and ancillary N,N ligands potentiate both the redox and chemical nuclease properties of bioinorganic copper complexes.
Supplementary Materials: The following are available online. Figure S1: The effect of acetonitrile on the DNA layer of the DNA biosensor; Figures S2–S6, S8, S9: Electrochemical response
of [Cu(TPMA)(phen)]2+ , [Cu(TPMA)]2+ , and [Cu(TPMA)(PD)]2+ at the gold electrode; Figure S7:
Scheme of quinone electrochemical reduction; Figure S10: Reduction of the pyridine ring;
Tables S1 and S2: Electrochemical parameters for the copper complexes obtained at the DNA biosensors; Figure S11: Washing of the DNA layer after interaction with [Cu(TPMA)(PD)]2+ ; Figures S12–S15:
The relationship between the oxidation and reduction wave peak currents versus the scan rate,
and the square root of the scan rate, at the DNA biosensor; Figures S16–S19: The stability of
the complexes at the DNA biosensor; Tables S3–S6: DNA nuclease efficacy of copper complexes.
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